Um die anderen Arten von Veröffentlichungen zu diesem Thema anzuzeigen, folgen Sie diesem Link: Biochemical markers.

Zeitschriftenartikel zum Thema „Biochemical markers“

Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an

Wählen Sie eine Art der Quelle aus:

Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "Biochemical markers" bekannt.

Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.

Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.

Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.

1

Ahmed, Mohamed H. "Biochemical Markers." American Journal of Clinical Pathology 127, no. 1 (2007): 20–22. http://dx.doi.org/10.1309/jxwum661t8vt1etx.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
2

Rothstein, Jeffrey. "Biochemical markers: Pro." Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (2002): S81. http://dx.doi.org/10.1080/146608202320374381.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
3

Mitsumoto, Hiroshi. "Biochemical markers: Con." Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (2002): S83. http://dx.doi.org/10.1080/146608202320374390.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
4

Strong, Michael J. "Biochemical markers: Summary." Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders 3, sup1 (2002): S85—S90. http://dx.doi.org/10.1080/146608202320374408.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
5

Sandberg, Dr K. "3. Biochemical markers." Animal Genetics 20, no. 1 (2009): 56–83. http://dx.doi.org/10.1111/j.1365-2052.1989.tb01910.x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
6

Seishima, Mitsuru, Makiko Suzuki, and Satoshi Maeda. "Atherosclerosis and biochemical markers." SEIBUTSU BUTSURI KAGAKU 48, no. 4 (2004): 143–46. http://dx.doi.org/10.2198/sbk.48.143.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
7

Selroos, Olof B. N. "Biochemical Markers in Sarcoidosis." CRC Critical Reviews in Clinical Laboratory Sciences 24, no. 3 (1986): 185–216. http://dx.doi.org/10.3109/10408368609110273.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
8

Đerić, Mirjana, Sunčica Kojić-Damjanov, Velibor Čabarkapa, and Nevena Eremić. "Biochemical Markers of Atherosclerosis." Journal of Medical Biochemistry 27, no. 2 (2008): 148–53. http://dx.doi.org/10.2478/v10011-008-0008-1.

Der volle Inhalt der Quelle
Annotation:
Biochemical Markers of AtherosclerosisThis paper is a brief review of some lipid parameters and serum markers of inflammation in a view of their predictive relevance for the atherosclerotic disease. A discourse on the importance of measuring different lipids and lipoproteins, concentration of LDL particles and apolipoprotein levels is still underway. Also, the recommendations for apolipoprotein (a), phenotypization and other lipid markers have not yet been established. In recent years the recommendations imply simultaneous measuring of multiple markers and calculating the lipid index values su
APA, Harvard, Vancouver, ISO und andere Zitierweisen
9

Kanis, John. "Biochemical markers in osteoporosis." Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997): 6–11. http://dx.doi.org/10.3109/00365519709168303.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
10

Ratcliffe, Anthony, and Markus J. Seibel. "Biochemical markers of osteoarthritis." Current Opinion in Rheumatology 2, no. 5 (1990): 770–76. http://dx.doi.org/10.1097/00002281-199002050-00014.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
11

Kanis, John A. "Biochemical markers in osteoporosis." Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (1997): 6–11. http://dx.doi.org/10.1080/00365519709168303.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
12

Jung, Rex E., Ronald A. Yeo, Stephen J. Chiulli, et al. "Biochemical markers of cognition." NeuroReport 10, no. 16 (1999): 3327–31. http://dx.doi.org/10.1097/00001756-199911080-00014.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
13

Ikizler, T. Alp. "Biochemical markers: Clinical aspects." Journal of Renal Nutrition 7, no. 2 (1997): 61–64. http://dx.doi.org/10.1016/s1051-2276(97)90039-x.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
14

Paselk, R. "Biochemical Markers for Cancer." Biochemical Education 13, no. 1 (1985): 43. http://dx.doi.org/10.1016/0307-4412(85)90154-2.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
15

Stadtman, E. R. "Biochemical markers of aging." Experimental Gerontology 23, no. 4-5 (1988): 327–47. http://dx.doi.org/10.1016/0531-5565(88)90036-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
16

Samoilova, I. G., M. V. Matveeva, and D. E. Galyukova. "Biochemical markers of autism." Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova 124, no. 1 (2024): 55. http://dx.doi.org/10.17116/jnevro202412401155.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
17

Duffy, M. J. "Biochemical markers as prognostic indices in breast cancer." Clinical Chemistry 36, no. 2 (1990): 188–91. http://dx.doi.org/10.1093/clinchem/36.2.188.

Der volle Inhalt der Quelle
Annotation:
Abstract Traditional prognostic markers in breast cancer include histological variables such as tumor size, grade, and axillary node status. In recent years some new potential prognostic markers of a biochemical nature have been described: estradiol receptors, progesterone receptors, epidermal growth factor receptors, erbB-2 proto-oncogene, and certain proteolytic enzymes. None of these new markers excels axillary node status as a prognostic marker. Biochemical markers can, however, be evaluated with use of minimal surgery and may help distinguish the minority of aggressive axillary-node-negat
APA, Harvard, Vancouver, ISO und andere Zitierweisen
18

Watts, Nelson B. "Clinical Utility of Biochemical Markers of Bone Remodeling." Clinical Chemistry 45, no. 8 (1999): 1359–68. http://dx.doi.org/10.1093/clinchem/45.8.1359.

Der volle Inhalt der Quelle
Annotation:
Abstract Remodeling is essential for bone health. It begins with resorption of old bone by osteoclasts, followed by the formation of new bone by osteoblasts. Remodeling is coupled (formation is linked to resorption). After middle age or perhaps beginning earlier, bone loss occurs because resorption exceeds formation. This imbalance is accentuated by estrogen deficiency as well as by many diseases and conditions. Biochemical markers that reflect remodeling and can be measured in blood or urine include resorption markers (e.g., collagen cross-links) and formation markers (e.g., alkaline phosphat
APA, Harvard, Vancouver, ISO und andere Zitierweisen
19

Cheung, K. L., S. E. Pinder, C. Paish, et al. "The Role of Blood Tumor Marker Measurement (Using a Biochemical Index Score and C-Erbb2) in Directing Chemotherapy in Metastatic Breast Cancer." International Journal of Biological Markers 15, no. 3 (2000): 203–9. http://dx.doi.org/10.1177/172460080001500310.

Der volle Inhalt der Quelle
Annotation:
The role of blood tumor markers in monitoring response in advanced breast cancer is established in endocrine therapy and standard chemotherapy. This study examines marker levels in patients receiving new chemotherapy regimens. Thirty patients were recruited into two multicenter trials in which docetaxel-based regimens were used in 15 patients. The other 15 received doxorubicin-based regimens. Biochemical response calculated from a score using CA15.3, CEA and ESR was compared with UICC response. Marker changes at 2, 4 and 5 months correlated with UICC response at 3, 41/2 and 6 months, respectiv
APA, Harvard, Vancouver, ISO und andere Zitierweisen
20

Adeli, Khosrow, Victoria Higgins, Michelle Nieuwesteeg, et al. "Biochemical Marker Reference Values across Pediatric, Adult, and Geriatric Ages: Establishment of Robust Pediatric and Adult Reference Intervals on the Basis of the Canadian Health Measures Survey." Clinical Chemistry 61, no. 8 (2015): 1049–62. http://dx.doi.org/10.1373/clinchem.2015.240515.

Der volle Inhalt der Quelle
Annotation:
Abstract BACKGROUND Biological covariates such as age and sex can markedly influence biochemical marker reference values, but no comprehensive study has examined such changes across pediatric, adult, and geriatric ages. The Canadian Health Measures Survey (CHMS) collected comprehensive nationwide health information and blood samples from children and adults in the household population and, in collaboration with the Canadian Laboratory Initiative on Pediatric Reference Intervals (CALIPER), examined biological changes in biochemical markers from pediatric to geriatric age, establishing a compreh
APA, Harvard, Vancouver, ISO und andere Zitierweisen
21

Khatoon, Arifa, Sumeet Verma, Gayatri Wadiye, and Anuprita Zore. "Molecular markers and their potentials." International Journal of Bioassays 5, no. 01 (2016): 4706. http://dx.doi.org/10.21746/ijbio.2016.01.003.

Der volle Inhalt der Quelle
Annotation:
The use of molecular markers, revealing polymorphism at the DNA level, has been playing an increasing part in plant molecular biotechnology and their genetic studies. There are three different types of markers viz. morphological, biochemical and DNA based molecular markers. These DNA based markers are differentiating in two types 1. Non PCR based (RFLP) and 2. PCR based markers (RAPD, AFLP, SSR, SNP etc.). Amongst others, the microsatellite DNA marker is one of the most widely used marker due to its easy use by simple PCR, followed by a denaturing gel electrophoresis. SNP (Single Nucleotide Po
APA, Harvard, Vancouver, ISO und andere Zitierweisen
22

Franco, Leonardo, and Mario Alejandro Ortíz Salazar. "Biochemical markers of bone metabolism." Revista Estomatología 18, no. 1 (2017): 30–34. http://dx.doi.org/10.25100/re.v18i1.5707.

Der volle Inhalt der Quelle
Annotation:
The quantity and quality of bone tissue renewal are dependent on the generation of new bone (deposition) mediated by osteoblasts and the loss (resorption) mediated by osteoclasts. For each of these processes there are important markers that can be measured in serum or urine.
 Resorption markers are products of metabolic degradation of bone matrix in particu-lar of the type I collagen (hydroxyproline, pyridinoline and deoxypyridinoline). In addition, the resorptive activity can also be evaluated through the tartrate resistant acid phosphatase (TRAP) and calcium-creatinine ratio in urine. B
APA, Harvard, Vancouver, ISO und andere Zitierweisen
23

Rosen, Clifford J., and Alan Tenenhouse. "Biochemical markers of bone turnover." Postgraduate Medicine 104, no. 4 (1998): 101–14. http://dx.doi.org/10.3810/pgm.1998.10.447.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
24

Accomando, Salvatore. "Biochemical markers in Celiac disease." Frontiers in Bioscience S2, no. 1 (2010): 313–17. http://dx.doi.org/10.2741/s66.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
25

Bapayeva, G. B. "Biochemical markers of premature birth." Journal of obstetrics and women's diseases 54, no. 3 (2005): 38–41. http://dx.doi.org/10.17816/jowd83449.

Der volle Inhalt der Quelle
Annotation:
Summary: In this article the results of the research of diagnostic importance of myoglobin determination in peripheral blood and amniotic fluid, fetal fibronectin examination in cervicovaginal composition contents of a pregnant woman are represented in prediction of premature birth.
APA, Harvard, Vancouver, ISO und andere Zitierweisen
26

Koshul’ko, P. A., M. S. Kovalenko, Yu V. Abalenihina, A. I. Mirov, O. E. Golofast, and E. D. Rokunov. "Biochemical markers of missed pregnancy." Problemy reproduktsii 27, no. 6 (2021): 138. http://dx.doi.org/10.17116/repro202127061138.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
27

Lyubimova, N. V., and N. E. Kushlinskiy. "Biochemical markers of bone metastasis." Advances in molecular oncology 2, no. 1 (2015): 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.061-075.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
28

Lyubimova, N. V., and N. E. Kushlinskiy. "Biochemical markers of bone metastasis." Advances in molecular oncology 2, no. 1 (2015): 061. http://dx.doi.org/10.17650/2313-805x.2015.2.1.61-75.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
29

Kovářů, H., F. Kovářů, A. Fišerová, P. Zelníčková, and E. Matalová. "Biochemical Markers of Lymphocyte Maturation." Acta Veterinaria Brno 71, no. 4 (2002): 503–8. http://dx.doi.org/10.2754/avb200271040503.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
30

Delmas, Pierre D. "Biochemical markers of bone turnover." Acta Orthopaedica Scandinavica 66, sup266 (1995): 176–82. http://dx.doi.org/10.3109/17453679509157687.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
31

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau, and H. Broll. "Biochemical markers in menopausal women." Scandinavian Journal of Clinical and Laboratory Investigation 57 (1997): 64–72. http://dx.doi.org/10.3109/00365519709168309.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
32

Apple, Fred. "Biochemical markers of thrombolytic success." Scandinavian Journal of Clinical and Laboratory Investigation 59 (1999): 60–66. http://dx.doi.org/10.3109/00365519909168328.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
33

Kemp, M., J. Donovan, H. Higham, and J. Hooper. "Biochemical markers of myocardial injury." British Journal of Anaesthesia 93, no. 1 (2004): 63–73. http://dx.doi.org/10.1093/bja/aeh148.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
34

Kerrigan, Richard W., and Ian K. Ross. "Extracellular Laccases: Biochemical Markers forAgaricusSystematics." Mycologia 80, no. 5 (1988): 689–95. http://dx.doi.org/10.1080/00275514.1988.12025602.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
35

Lyubimova, N. V., T. K. Churikova, M. G. Toms, and N. E. Kushlinskiy. "BIOCHEMICAL MARKERS OF NEUROENDOCRINAL TUMORS." Tambov University Reports. Series: Natural and Technical Sciences 21, no. 2 (2016): 494–510. http://dx.doi.org/10.20310/1810-0198-2016-21-2-494-510.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
36

Krstic, Danijela, Nenad Tomic, Branimir Radosavljevic, et al. "Biochemical Markers of Renal Function." Current Medicinal Chemistry 23, no. 19 (2016): 2018–40. http://dx.doi.org/10.2174/0929867323666160115130241.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
37

Demers, Laurence M., Luis Costa, and Allan Lipton. "Biochemical Markers and Skeletal Metastases." Clinical Orthopaedics and Related Research 415 (October 2003): S138—S147. http://dx.doi.org/10.1097/01.blo0000092979.12414.54.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
38

Thompson, R. P. H. "Biochemical markers of liver disease." Current Opinion in Gastroenterology 1, no. 3 (1985): 377–89. http://dx.doi.org/10.1097/00001574-198505000-00002.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
39

Matull, W. R. "Biochemical markers of acute pancreatitis." Journal of Clinical Pathology 59, no. 4 (2006): 340–44. http://dx.doi.org/10.1136/jcp.2002.002923.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
40

Engler, H., B. Thürlimann, and F. Riesen. "Biochemical Markers of Bone Remodelling." Oncology Research and Treatment 19, no. 2 (1996): 126–31. http://dx.doi.org/10.1159/000218778.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
41

Griesmacher, A., P. Peichl, P. Pointinger, R. Mateau, and H. Bröll. "Biochemical markers in menopausal women." Scandinavian Journal of Clinical and Laboratory Investigation 57, sup227 (1997): 64–72. http://dx.doi.org/10.1080/00365519709168309.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
42

Apple, Fred S. "Biochemical markers of thrombolytic success." Scandinavian Journal of Clinical and Laboratory Investigation 59, sup230 (1999): 60–66. http://dx.doi.org/10.1080/00365519909168328.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
43

Gao, F., and D. N. F. Harris. "Biochemical markers of cerebral damage." European Journal of Anaesthesiology 14, no. 2 (1997): 113–17. http://dx.doi.org/10.1097/00003643-199703000-00001.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
44

De Jongh, R., C. De Deyne, G. Kenis, G. Vundelinckx, L. Merckx, and R. Heylen. "Biochemical markers of brain ischaemia." European Journal of Anaesthesiology 15, Supplement 17 (1998): 14–15. http://dx.doi.org/10.1097/00003643-199801001-00011.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
45

Crofton, P. M., H. F. Stirling, E. Schönau, et al. "Biochemical Markers of Bone Turnover." Hormone Research 45, no. 1 (1996): 55–58. http://dx.doi.org/10.1159/000184832.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
46

Rambotti, Pietro. "Biochemical markers in lymphoproliferative diseases." Critical Reviews in Oncology/Hematology 2, no. 4 (1985): 297–321. http://dx.doi.org/10.1016/s1040-8428(85)80006-8.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
47

Shepherd, J. "Biochemical risk markers of CHD." Atherosclerosis 144 (May 1999): 144. http://dx.doi.org/10.1016/s0021-9150(99)80558-9.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
48

Seibel, Markus J. "Biochemical markers of bone remodeling." Endocrinology and Metabolism Clinics of North America 32, no. 1 (2003): 83–113. http://dx.doi.org/10.1016/s0889-8529(02)00077-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
49

Garnero, Patrick, and Pierre D. Delmas. "BIOCHEMICAL MARKERS OF BONE TURNOVER." Endocrinology and Metabolism Clinics of North America 27, no. 2 (1998): 303–23. http://dx.doi.org/10.1016/s0889-8529(05)70007-4.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
50

Gavaghan, Mary. "Biochemical Markers in Myocardial Injury." AORN Journal 70, no. 5 (1999): 839–54. http://dx.doi.org/10.1016/s0001-2092(06)61303-3.

Der volle Inhalt der Quelle
APA, Harvard, Vancouver, ISO und andere Zitierweisen
Wir bieten Rabatte auf alle Premium-Pläne für Autoren, deren Werke in thematische Literatursammlungen aufgenommen wurden. Kontaktieren Sie uns, um einen einzigartigen Promo-Code zu erhalten!